We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Loses Another Round in Fight to Delay Generic Nasonex
Merck Loses Another Round in Fight to Delay Generic Nasonex
June 18, 2013
Merck’s ‘353 patent for Nasonex in the U.S. is valid but won’t be infringed upon by Apotex’s 2009 ANDA for a generic version of the popular product, a federal appeals court ruled June 10.